Search Results for “”

Showing 21-30 of 115

September 11, 2019

Weekly News Roundup 9/6 to 9/12

This week: Find out if you follow the most popular pet influencers, the FDA recalls more pet food products, and gender discrimination in the veterinary profession. 

July 25, 2019

New study offers more fodder to spay/neuter discussion

The age at which large-breed dogs are spayed or neutered has become a hot topic with regard to obesity and nontraumatic orthopedic injuries, and a new study published July 17 in the journal PLOS ONE and based on data from the Morris Animal Foundation Golden Retriever Lifetime Study provides more information for veterinarians.

April 29, 2019

FDA: Jurox voluntarily recalls two lots of Alfaxan after reports of adverse side effects, including one death

After receiving adverse reports involving five animals, Australia-based Jurox Animal Health voluntarily recalled two lots of the widely used intravenous injectable anesthetic Alfaxan unpreserved last week, according to the US Food and Drug Administration (FDA). The reason for the recall: The presence of aluminum phosphate precipitate, which, when injected, presents a possible risk of blood vessel inflammation and formation of potentially life-threatening blood clots.

January 24, 2019

AVMA Council on Education seeking volunteers

You could have a say on the future of veterinary education. The American Veterinary Medical Association (AVMA) Council on Education (COE) Selection Committee is seeking interested and qualified veterinarians to serve on the council. Per the AVMA, “This is one of the most important volunteer roles that AVMA members can fill.”

August 29, 2018

AAHA joins other veterinary leaders in call for strong licensure requirements

When it’s all about quality of care, everyone’s on board. The American Veterinary Medical Association (AVMA), American Association of Veterinary State Boards (AAVSB), Association of American Veterinary Medical Colleges (AAVMC) and National Association of Veterinary Technicians in America (NAVTA) on Thursday released a joint statement of support for

December 14, 2017

FDA says shortage of pain relief drugs due to manufacturing issue

The U.S. Food and Drug Administration (FDA) is reporting a shortage of three pain relief drugs: fentanyl, morphine and hydromorphone. The shortage is due to upgrades being made at a pharmaceutical manufacturing plant in Kansas, and is unrelated to any federal policies on opioids or manufacturing quotas, according to FDA officials.

Refine Results


NEWStat

keyboard_arrow_down keyboard_arrow_up